|1.||Tokura, Yoshiki: 3 articles (08/2013 - 05/2006)|
|2.||Kadhe, Ganesh: 2 articles (12/2014 - 07/2014)|
|3.||Nenoff, P: 2 articles (04/2014 - 10/2004)|
|4.||Noguchi, Norihisa: 2 articles (08/2013 - 09/2012)|
|5.||Wollenberg, Andreas: 2 articles (01/2012 - 01/2010)|
|6.||Kobayashi, Miwa: 2 articles (12/2011 - 05/2006)|
|7.||Appelbaum, Peter C: 2 articles (10/2006 - 12/2004)|
|8.||Jacobs, Michael R: 2 articles (10/2006 - 12/2004)|
|9.||Singh, Surinder P: 1 article (05/2015)|
|10.||Gupta, Anita K: 1 article (05/2015)|
03/01/2011 - "Therefore, nadifloxacin can be used as an effective and safe treatment option in the management of mild to moderate acne in Asian subjects."
10/01/1991 - "Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base."
03/01/2012 - "Most of the mean irritation scores were 0, and all were < 1. Combined application of nadifloxacin with any of the other four topical anti-acne products did not lead to substantial intolerance reactions compared with the effects after application of the products alone."
03/01/2012 - "To compare the dermal irritation produced by an anti-acne cream containing 1% nadifloxacin with that produced by additional treatment with four different topical anti-acne products in a 21-day open application test in 40 healthy volunteers. "
03/01/2012 - "Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents."
01/01/2012 - "Strikingly, patients' rash severity improved significantly over three weeks of treatment with topical mometason furoate cream, topical prednicarbate cream plus nadifloxacin cream, as well as topical prednicarbate cream plus nadifloxacin cream plus systemic isotretinoin. "
09/01/2010 - "The reactive skin protocol was built up as follows: grade 1 exanthema: topical cleansing syndet (Dermowas®) + topical metronidazole cream (Rosiced®); grade 2 exanthema: grade 1 treatment + oral minocycline 50 mg twice per day; grade 3 exanthema: grade 2 treatment + topical corticoid (Dermatop®) + topical nadifloxacin (Nadixa®). "
|3.||Bacterial Infections (Bacterial Infection)
12/01/2014 - "A significant reduction in the mean scores for bacterial infection symptoms in the nadifloxacin groups was observed when compared to mupirocin, framycetin and fusidic acid groups. "
04/01/2014 - "Bacterial infections are treated topically with antiseptic agents (octenidine), and in some cases with topical antibiotics (nadifloxacin, gentamicin). "
12/01/2014 - "Efficacy and safety of nadifloxacin for bacterial skin infections: results from clinical and post-marketing studies."
12/01/2014 - "Nadifloxacin, a fluoroquinolone, is a new alternative topical agent in the treatment of bacterial skin infection with minimal AEs."
12/01/2014 - "However, there is paucity of data comparing efficacy and safety of 1% nadifloxacin with other anti-bacterials for skin infections in Indian patients. "
04/24/2010 - "Pseudomonas fingernail infection successfully treated with topical nadifloxacin in HIV-positive patients: report of two cases."
10/01/2006 - "Nadifloxacin has potential as a topical agent for short-term treatment of skin infections. "
|4.||Fusidic Acid (Fucithalmic)
|7.||Framycetin (Framycetin Sulfate)
|10.||Tretinoin (Retinoic Acid)
|2.||Drug Therapy (Chemotherapy)